CDC- Four-year effectiveness of covid-19 vaccines against severe disease and asymptomatic infection: the covidvac@spain study
INDEPENDENT POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: FOUNDATION FOR BIOMEDICAL RESEARCH OF LA PAZ UNIVERSITY HOSPITAL
- Execution start: 31/08/2021
- End of execution: 31/08/2025
- PI: CARMEN HIDALGO TENORIO